Worldwide Veterinary Ocular Medicine Spending on Canines Treatments (2024–2032)

Rising incidences of ocular ailments among domestic animals increase spending patterns across the veterinary ocular medicine market. In 2024, expenditure on canine ocular treatments was recorded at USD 272,290.56 Th, reflecting the growing awareness of eye health management among pet owners. This steady progression continues as 2025 is estimated to reach USD 287,604.85 Th, underscoring a consistent emphasis on clinical advancements and diagnostic precision. The global veterinary ocular medicine landscape continues to expand as specialised treatments and preventive care gain traction across developed and emerging markets.
Over the forecast horizon (2026–2032), the veterinary ocular medicine market is projected to advance considerably, with spending expected to escalate to USD 343,421.54 Th by 2028 and reach USD 471,064.96 Th by 2032. This expansion is anticipated to be driven by enhanced access to ophthalmic technologies, increased adoption of precision therapies, and supportive veterinary infrastructure. The Worldwide Veterinary Ocular Medicine Spending on Canine Treatments market is poised for sustainable growth as innovation, affordability, and clinical reliability define its long-term trajectory.